As you already know, the third quarter was terrible for most smart money investors, who suffered significant losses amid the market turmoil caused by a slowdown of the global ...
Keep Reading →
November 5 - Hedge Funds, News, Tech
When it comes to activist investing, Dan Loeb is one of the best in the business, generating strong returns through pushing companies to implement changes that maximize shareholder...
Keep Reading →
November 3 - Hedge Funds, News, Tech
With the earnings season in progress, investors can take a step back from following macroeconomic news and focus on the financial results reported by individual companies.
Keep Reading →
October 27 - Earnings Report, Market Movers, News
According to an amended 13D filing activist investor Dan Loeb's Third Point now owns about 53.85 million shares of Baxter International Inc (NYSE:BAX), which marks an increase...
Keep Reading →
September 30 - Hedge Funds, News
Billionaire James Dinan founded York Capital Management, a New York-based long/short equity hedge fund, in 1991. Prior to founding York, Mr.
Keep Reading →
August 24 - Hedge Fund Analysis, Hedge Funds, News
Renowned activist investor Dan Loeb's Third Point recently filed its 13F form with the Securities and Exchange Commission, which revealed its equity portfolio for the end of ...
Keep Reading →
August 17 - Hedge Funds, News
A couple of days after disclosing a new position in Baxter International Inc (NYSE:BAX), Dan Loeb's Third Point issued an amended filing, in which it reported that it owns 52...
Keep Reading →
August 7 - Hedge Funds, News
Baxalta Inc (NYSE:BXLT) was recently spun-off from Baxter International Inc (NYSE:BAX) on July 1st, 2015.
Keep Reading →
August 6 - Dividend Stocks, News, Stock Analysis
In a new filing with the Securities and Exchange Commission, Dan Loeb's Third Point disclosed a large activist stake in Baxter International Inc (NYSE:BAX) and a letter sent to...
Keep Reading →
August 5 - Hedge Funds, News
Alexion Pharmaceuticals, Inc.
Keep Reading →
June 30 - Hedge Funds, News
In the midst of an aging population, the United States remains the market leader for medical devices, accounting for about one-third of the worldwide market.
Keep Reading →
September 20 - News
Dividend investors would be wise to focus not just on a stock's current yield but also on the long-term growth potential of its dividends.
Keep Reading →
September 17 - Dividend Stocks, News
A company with a modus operandi of tackling rare and very rare diseases might not necessarily jump out as a great investment, but this company has banked more than a billion...
Keep Reading →
September 9 - News
With August winding down, summer won't be around much longer. Several health-care stocks still had hot days this past week, though.
Keep Reading →
September 1 - News
The health care sector can be daunting for some investors, and there are some good reasons why many people won't go near health care stocks.
Keep Reading →
August 27 - News
In today’s marketplace, there are many metrics market participants can use to track stocks. A couple of the most under-the-radar are hedge fund and insider trading interest.
Keep Reading →
August 26 - News
In the 21st century investor’s toolkit, there are many indicators shareholders can use to track their holdings.
Keep Reading →
August 23 - News
The Medicines Company (NASDAQ:MDCO) is a mid-cap value stock that jumped by 21% in the last 12 months, trading at a 52-week price range of $20.04-$37.40.
Keep Reading →
August 23 - News
To many traders, hedge funds are perceived as delayed, outdated investment tools of a forgotten age.
Keep Reading →
August 22 - News
In the financial world, there are plenty of indicators investors can use to watch Mr. Market. A pair of the most innovative are hedge fund and insider trading activity.
Keep Reading →
August 22 - News
Paul Tudor Jones is the manager of Tudor Investment Corp, focusing on equity, debt, venture capital, currency and the commodity markets.
Keep Reading →
August 14 - Hedge Funds
Obesity rates are soaring in the United States. According to the American Heart Association, 155 million adults and 24 million children are overweight or obese.
Keep Reading →
August 12 - News
The performance of Baxter International Inc. (NYSE:BAX), the world’s second-largest maker of dialysis products, has been lagging the market with 7.38% gain YTD as of Aug 2, ...
Keep Reading →
August 10 - News
Thanks to an expanding product portfolio, increasing healthcare spending, and explosive growth in the emerging markets, the healthcare industry has been growing at a stellar rate...
Keep Reading →
August 5 - News
China's markets have been anything but an investor paradise this year.
Keep Reading →
August 5 - News
Blood collecting, testing, and treatments are key components of the healthcare system.
Keep Reading →
August 3 - News
The investing waters can get pretty choppy from time to time with a developmental stage company. A look at the five-year chart of Momenta Pharmaceuticals, Inc.
Keep Reading →
August 2 - News
It isn't very often that an agency sometimes accused of over-regulating an industry can be ridiculed for not regulating enough, but that's exactly where the Food and Drug Administration...
Keep Reading →
August 2 - News
This market presents a ripe environment for dividend paying stocks.
Keep Reading →
August 1 - News
After a volatile few months, interest rates appear to be settling back into a tight trading range, For example, the yield on the 10-year U.S.
Keep Reading →
July 30 - News
Halozyme Therapeutics, Inc. (NASDAQ:HALO) moved higher by 25% on Friday behind the news of a positive opinion by the European Medicines Agency's Committee for Medicinal Products...
Keep Reading →
July 29 - News
Medical device stocks are an excellent place to be if you are still wary of the macro-economy.
Keep Reading →
July 23 - News
On July 9, Intuitive Surgical, Inc.
Keep Reading →
July 17 - News
Recent deals have performed so well that investment bankers are hustling the next crop up to the starting gate at a rapid pace. You can't blame them.
Keep Reading →
July 17 - News
The U.S. is the world’s leading medical device manufacture. Becton, Dickinson and Co. (NYSE:BDX), Baxter International Inc.
Keep Reading →
July 15 - News
Love it or hate it, the Patient Protection and Affordable Care Act -- commonly referred to as Obamacare -- changes the health care landscape.
Keep Reading →
July 5 - News
Baxter International Inc. (NYSE:BAX), one of the fastest-growing healthcare multinational corporations of America, has a long history of strong financial credentials.
Keep Reading →
July 1 - News
Investors have reasons to be wary about small-cap biotech companies, particularly those ambitious start-ups which have been sprouting like mushrooms in the market this year.
Keep Reading →
July 1 - News
At the London Value Investor Conference, famous value investor Michael Price pitched Hospira, Inc. (NYSE:HSP) as one of his favorite stocks.
Keep Reading →
July 1 - News
Moreover, there is a rising demand for good healthcare in developing countries in the Asia-Pacific region.
Keep Reading →
June 28 - News
After a series of failures, one is forced to wonder whether the medical fraternity, including the research and development wing of Eli Lilly & Co.
Keep Reading →
June 27 - News
At the London Value Investor Conference, famous value investor Michael Price pitched Hospira, Inc. (NYSE:HSP) as one of his favorite stocks.
Keep Reading →
June 24 - News
There is plenty of good news to support the 30% move made by Baxter International Inc. (NYSE:BAX) shares in the past year.
Keep Reading →
June 21 - News
Earlier this month, Baxter International Inc. (NYSE:BAX) reported that the clinical trials for the treatment of Alzheimer’s disease (Gammagard) had failed.
Keep Reading →
May 29 - News
Baxter International Inc. (NYSE:BAX) was in 35 hedge funds' portfolio at the end of March. BAX has seen an increase in hedge fund interest lately.
Keep Reading →
May 28 - News
If you'd ask most investors, hedge funds are viewed as slow, old investment tools of the past.
Keep Reading →
May 24 - News
Alzheimer's is a debilitating neurodegenerative disorder affecting approximately 5 million Americans, yet its causes are remarkably enigmatic. Nonetheless, pharma and biotech...
Keep Reading →
May 17 - News
Continuing on with the dividend trend that my recent articles have been focusing upon, I’d like to now take a look at some solid healthcare companies.
Keep Reading →
April 28 - News
